News Archives - Page 134 of 1183 - BioHealth Innovation

Cursor and Emergent BioSolutions unveils 7th pandemic CDMO contract this time for Humanigen s late stage antibody hopeful Fierce Pharma

News

August 3, 2022

Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this time to help crank out Humanigen’s late-stage antibody…

admin

Love0

News

August 3, 2022

“BioTalk with Rich Bendis” Podcast Featured in BioBuzz Podcasts to Follow Now

In a job market that’s become increasingly competitive and employer-driven, it’s imperative for both active and passive job candidates to…

admin

Love0

News

August 3, 2022

REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II

FDA will consider an accelerated approval pathway for RGX-121; BLA filing expected in 2024 Pivotal program is active and enrolling…

admin

Love0

News

August 3, 2022

NIH Applicant Assistance Program Accepting Applications

The National Institutes of Health (NIH) Applicant Assistance Program (AAP) is designed to assist small businesses who have never received…

admin

Love0

News

August 3, 2022

Emergent BioSolutions inks deal for smallpox newcomer Tembexa

Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid overdoses, is expanding its arsenal…

admin

Love0

News

August 3, 2022

GSK enters agreement with 12 EU countries – BioProcess InsiderBioProcess International

GlaxoSmithKline (GSK) has signed an agreement to reserve, produce, and supply its influenza vaccine Adjupanrix to 12 European countries. Under…

admin

Love0

News

August 3, 2022

Biotech & Beer -NOVA – Registration

You are invited to our exclusive Biotech & Beer networking event at The Black Sheep Restaurant on August 16th from…

admin

Love0

News

August 1, 2022

BioHealth Innovation Announces New Life Sciences Business Strategist Kelly Murphy

ROCKVILLE, MARYLAND, August xx, 2022 – BioHealth Innovation Inc. (BHI) is pleased to welcome Kelly Murphy, M.S., as a new…

admin

Love0

News

August 1, 2022

Medical Device I-Corps

The Fischell Institute is working with University of Maryland (UMD) I-Corps representatives to plan a Medical Device I-Corps program, targeting…

admin

Love0

News

August 1, 2022

Arcellx inks deal for Rockville expansion – Washington Business Journal

The newly minted public company has signed a lease for 60,000 square feet. Image: 800 King Farm Blvd. will be…

admin

Love0

News

Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

“BioTalk with Rich Bendis” Podcast Featured in BioBuzz Podcasts to Follow Now

REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II

NIH Applicant Assistance Program Accepting Applications

Emergent BioSolutions inks deal for smallpox newcomer Tembexa

GSK enters agreement with 12 EU countries – BioProcess InsiderBioProcess International

Biotech & Beer -NOVA – Registration

BioHealth Innovation Announces New Life Sciences Business Strategist Kelly Murphy

Medical Device I-Corps

Arcellx inks deal for Rockville expansion – Washington Business Journal

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search